Stock listing

Frankfurt:S0N enGene Holdings Inc. Aktie

German listing (Frankfurt) of enGene Holdings Inc. · home listing Dusseldorf:S0N

Follow enGene Holdings Inc. into a list and get an email when it puts out news.

enGene Holdings Inc. logo
Ticker
Frankfurt:S0N
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

enGene Announces Name Change to enGene Therapeutics Inc.

Apr 7, 2026

enGene Reports First Quarter 2026 Financial Results and Provides Business Update

Mar 9, 2026

enGene to Participate in Upcoming Investor Conferences

Feb 20, 2026

enGene to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

Feb 4, 2026

enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc.

Jan 20, 2026

enGene Reports Full Year 2025 Financial Results and Provides Business Update

Dec 22, 2025

Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors

Dec 16, 2025

Issued by another party

enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness

Dec 2, 2025

enGene to Present at the Piper Sandler 37th Annual Healthcare Conference

Nov 25, 2025

enGene Announces Pricing of $130 Million Public Offering of Common Shares and Pre-Funded Warrants

Nov 13, 2025

All enGene Holdings Inc. news

Decks

enGene Holdings Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 14 in all · newest Apr 7, 2026 · oldest 2025
Decks
3 decks · latest Sep 15, 2023

Where enGene Holdings Inc. is listed

ListingExchangeCountryCurrency
Dusseldorf:S0N · Home listingDusseldorfGermanyEUR
NASDAQ:ENGNNASDAQUnited StatesUSD
BOATS:ENGNBOATSUnited StatesUSD
Frankfurt:S0N · This pageFrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about enGene Holdings Inc.